WesBanco Bank’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-120,000
Closed -$1.43M 722
2026
Q1
$1.43M Hold
120,000
0.04% 297
2025
Q4
$1.85M Hold
120,000
0.05% 247
2025
Q3
$2.6M Hold
120,000
0.07% 197
2025
Q2
$2.67M Buy
120,000
+80,637
+205% +$1.79M 0.08% 193
2025
Q1
$935K Hold
39,363
0.03% 323
2024
Q4
$833K Hold
39,363
0.03% 346
2024
Q3
$1.27M Hold
39,363
0.04% 283
2024
Q2
$936K Buy
39,363
+13,700
+53% +$352K 0.04% 315
2024
Q1
$766K Buy
+25,663
New +$803K 0.03% 344
2023
Q4
Sell
-25,663
Closed -$751K 522
2023
Q3
$751K Hold
25,663
0.03% 332
2023
Q2
$1.16M Buy
25,663
+9,008
+54% +$344K 0.05% 250
2023
Q1
$574K Hold
16,655
0.02% 387
2022
Q4
$464K Buy
+16,655
New +$441K 0.02% 415
2022
Q3
Sell
-29,607
Closed -$856K 502
2022
Q2
$856K Hold
29,607
0.04% 291
2022
Q1
$1.63M Hold
29,607
0.06% 218
2021
Q4
$1.58M Hold
29,607
0.06% 228
2021
Q3
$1.25M Buy
+29,607
New +$1.51M 0.05% 258

Other funds holding SGRY

WesBanco Bank's SGRY Position: Q2 2026 in Review

WesBanco Bank sold out of Surgery Partners (SGRY) in Q2 2026, closing a stake of 120,000 shares — an estimated $1.43M sold.

WesBanco Bank first reported a position in SGRY in Q3 2021 and held it in 17 quarters. The position peaked at $2.67M in Q2 2025. 58 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • WesBanco Bank reported no remaining Surgery Partners position as of Q2 2026 after selling out during the quarter.
  • WesBanco Bank sold 120,000 Surgery Partners shares in Q2 2026, an estimated $1.43M.
  • WesBanco Bank first reported a position in Surgery Partners in Q3 2021 and held it in 17 quarters.
  • WesBanco Bank's Surgery Partners position peaked at $2.67M in Q2 2025.
  • 58 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.